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IDENTIFICATION OF THE TIDEMARK LINE OF CALCIFICATION IN
OSTEOARTHRITIC CARTILAGE USING A STAIN FOR ALKALINE
PHOSPHATASE
C.S. Black, P.K. Crepeau, I.D. Shefﬁeld, J.R. Macdonald, D.J. Wootton,
M. Baek, D.L. Eggett, P.R. Reynolds, D.L. Kooyman. Brigham Young Univ.,
Provo, UT, USA
Purpose:While osteoarthritis (OA) has traditionally been classiﬁed as a
“wear and tear” disease, recent studies have shown that this disease is
due to an inﬂammatory response. Our lab has made signiﬁcant strides
in identifying key biomarkers that are present throughout the pro-
gression of OA. In past histochemical staining, we and others have
noticed a faint line located between the subchondral bone and the
articular surface in knee joints, presumed to be the tidemark or line of
demarcation between calciﬁed and uncalciﬁed cartilage. This would
suggest that cartilage in osteoarthritic joints is lost in part due to a
metabolic calciﬁcation process. The purpose of this study is to prove
quantitatively that the faint line is the tidemark and not simply an
artifact of the staining process.
Methods: Mouse knees (n ¼ 8) were embedded and stained for both
Alkaline Phosphatase (ALP) and Safranin-O/Fast Green (Saf-O, FG). ALP,
a metallo hydrolase enzyme that is active during tissue calciﬁcation,
was used to identify the true location of the tidemark. Using Adobe
Photoshop, pictures from the two stains were overlaid for tidemark
comparison. A standard-sized box was cropped over the two pictures
and the “lasso” tool was used to outline the area between the articular
surface and the tidemark in each stain. The area of each of the outlined
pictures was then calculated in order to compare the tidemark location
between the two stains. To ensure that the anatomy was nearly iden-
tical between samples and that speciﬁc anatomical landmarks would
match up when overlaid, the comparison was only made between
consecutive slides taken from the same sample. Data were analyzed
using a paired T-test.
Results: A comparison of the areas outlined in both stains resulted in a
T-value of 0.51 that equated to a P-value greater than 0.6 with a
standard deviation of 5.87%. Thus, we can conclusively say that the thin
line observed in the Safranin-O/Fast Green stain is indeed the tidemark
line of calciﬁcation we see in the Alkaline Phosphatase stain.
Conclusions: Proving that the thin line observed between subchondral
bone and the articular surface after Saf-O, FG staining is the tidemark
demarcation of calciﬁcation and not an artifact is important. It allows us
and others to compare the progression of the tidemark over multiple
age groups and/or models using the simple Saf-O, FG stain. It lends
support to the idea that OA is not simply a “wear and tear” disease.
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INTRA-CARTILAGE DELIVERY OF DEXAMETHASONE FROM AVIDIN, A
CATIONIC DRUG CARRIER, ATTENUATES INJURY INDUCED CATABOLIC
EFFECTS IN KNEE JOINTS OF MATURE RABBITS IN VIVO
A.G. Bajpayee y, A. Scheu z, R.D. Vega x, N.H. Varady y, I.A. Yannatos 4,
R.M. Porter x, A.J. Grodzinsky y. yMIT, Cambridge, MA, USA; zClínica
Alemana de Santiago, Santiago, Chile; xBIDMC, Boston, MA, USA; k Tufts
Univ., Medford, MA, USA
Purpose: Avidin (Av), a positively charged protein, exhibits ideal
characteristics for targeted i.a drug delivery into cartilage due to
its small-enough size (66kDa) and optimal net charge (between
þ6 & þ20). The high concentration of negatively charged proteo-
glycans inside cartilage offers a high site density (Nt¼2920mM) for
Av binding. In previous studies with cartilage explants, this
property of weak-reversible binding allowed Av to penetrate
through full thickness of cartilage yet have a long retention time.
Donnan partitioning of Av suggested at least a six-fold upward
partitioning factor at the synovial ﬂuid-tissue interface. This would
result in a steep intra-tissue concentration gradient that would
signiﬁcantly enhance its transport rate and uptake. We therefore
hypothesized that the relatively weak but reversible nature of
electrostatic Av binding to GAGs inside cartilage would enable a
long half-life (t1/2) of Av when injected i.a into rabbit knee joints
in-vivo. Functionalization of drugs to Av could thereby provide a
unique targeted intra-cartilage delivery mechanism.Dexamethasone (DEX) in low doses is known to suppress cyto-
kine-induced catabolic effects. Av-DEX conjugations were synthe-
sized to enable sustained release of DEX inside cartilage. Here, we
show that only a single dose Av-DEX is enough to suppress IL-1
induced GAG loss over 3 weeks in-vitro. Additionally, we evaluated
therapeutic efﬁcacy of Av-DEX in a rabbit ACLT model of PTOA and
compare it with soluble DEX
Methods: In-vitro bioactivity of Av-DEX: Calf cartilage explants were
cultured in Lg DMEM containing IL-1(1ng/ml) with 1 time dose of 3
types of Av-DEX compounds: X (fast release ester linker, t1/2¼ 15h),
Y (slow release hydrazone, t1/2 ¼58h), Z (1:1 molar ratio of X & Y)
& soluble DEX (100mM) for 22 days. sGAG loss was measured by
DMMB assay. In vivo rabbit studies (approved by IACUC BIDMC): In
one study, right knee joints of twelve 12m old New Zealand rabbits
were i.a injected with Av-red. After 1d, 4d & 7d rabbits were sac-
riﬁced. Av uptake-retention was measured in following joint tissues
using plate reader: lateral & medial tibia cartilage (LTC, MTC);
femoral cartilage (LFC, MFC); groove & patella cartilage (GCþPC);
cruciate ligaments (ACL, PCL); menisci (LM, MM); patella, quadriceps
& extensor tendons (PT, QT, ET). In a second study, 60 rabbits
underwent ACL transection (ACLT). Contralateral left knees were
used as operated controls. 1w after surgery, ACLT knees were
injected with 600ml of saline, soluble DEX & Av-DEX (Z, 0.5mg DEX);
N¼10 rabbits each treatment. Rabbits were euthanized at 3w or 9w
post-surgery. Gross morphology of joints was assessed qualitatively
& by histology for osteophytes, soft tissue ﬁbrillation & lesions.
Articular cartilage was examined for expressions of IL-1b, ACAN,
Col2, MMP-1 & 3(qPCR, normalized by GAPDH). Static & dynamic
equilibrium moduli were measured on LTC by applying ramp-hold
displacements and sinusoidal waveform respectively using mechan-
ical spectrometer. Collagen content was measured by hydroxyproline
assay
Results: 1 dose Av-DEX suppressed IL-1 induced GAG loss from
cartilage by a signiﬁcantly greater amount than soluble DEX (Fig 1A).
Fig 1B-C compares retention of Av-red in rabbit knee post 24h i.a
injection with that in untreated control knees; by comparison, no
traces of the same-size electrically neutral version of Av were found.
Fig 1D shows Av half-life as a function of square of tissue thickness
& GAG content; longest t1/2 of 154h was measured in the thickest
cartilage, LTC. Fig 2A-C show mRNA expressions in rabbit cartilage
3w post ACLT surgery. IL-1b, MMP-1 & ACAN expressions were
signiﬁcantly suppressed with Av-DEX treatment compared to oper-
ated control and soluble DEX. Treatment with DEX or Av-DEX did
not restore ACLT induced loss of tissue stiffness (Fig 2D). Collagen
content remained unchanged (Fig 2E), however, GAG content
reduced in Av-DEX treated patellar cartilage compared to control
(Fig 2F)
Conclusions: Av has the unique property to rapidly diffuse into carti-
lage deep zones and remain bound for extended time periods in vivo.
No other such structures have been demonstrated yet for i.a injected
intra-cartilage drug delivery. Av-DEX effectively suppressed IL-1
induced catabolic effects in-vitro and in vivo (rabbits) over 3w. Data
collection for 9w study is underway.
